pubmed-article:8720287 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0035525 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8720287 | lifeskim:mentions | umls-concept:C0556895 | lld:lifeskim |
pubmed-article:8720287 | pubmed:dateCreated | 1996-10-11 | lld:pubmed |
pubmed-article:8720287 | pubmed:abstractText | Chronic hepatitis C may lead to cirrhosis and hepatocellular carcinoma in a subset of patients. Because response rates with interferon alfa therapy are unsatisfactory, new therapies are needed. | lld:pubmed |
pubmed-article:8720287 | pubmed:language | eng | lld:pubmed |
pubmed-article:8720287 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8720287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8720287 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8720287 | pubmed:issn | 0168-8278 | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:AlbertiAA | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:PontissoPP | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:ChemelloLL | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:GuidoMM | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:CavallettoLL | lld:pubmed |
pubmed-article:8720287 | pubmed:author | pubmed-author:Bernardinello... | lld:pubmed |
pubmed-article:8720287 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8720287 | pubmed:volume | 23 Suppl 2 | lld:pubmed |
pubmed-article:8720287 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8720287 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8720287 | pubmed:pagination | 8-12 | lld:pubmed |
pubmed-article:8720287 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:meshHeading | pubmed-meshheading:8720287-... | lld:pubmed |
pubmed-article:8720287 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:8720287 | pubmed:articleTitle | The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. | lld:pubmed |
pubmed-article:8720287 | pubmed:affiliation | Clinica Medica 2, University of Padova, Italy. | lld:pubmed |
pubmed-article:8720287 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8720287 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8720287 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:8720287 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8720287 | lld:pubmed |